<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="53754">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02047331</url>
  </required_header>
  <id_info>
    <org_study_id>KA12/269</org_study_id>
    <nct_id>NCT02047331</nct_id>
  </id_info>
  <brief_title>Periarticular Injection Versus Fascia Iliaca Block for Total Knee Arthroplasty</brief_title>
  <official_title>Multimodal Periarticular Injection Versus Fascia Iliaca Compartment Block for Total Knee Arthroplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Baskent University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Baskent University</source>
  <oversight_info>
    <authority>Turkey: Ethics Committee</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study, the aim is to compare the efficacy of Periarticular multimodal  drug
      injection(group PI) and Fascia Iliaca Compartment Block ( group FI)for total knee
      arthroplasty.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Total knee arthroplasty is very painful surgical intervention.Patients were assigned to 2
      groups to receive either periarticular multimodal  drug injection or fascia iliaca
      compartment block for postoperative pain.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2013</start_date>
  <completion_date type="Actual">August 2013</completion_date>
  <primary_completion_date type="Actual">July 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Caregiver, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Postoperative pain scores of periarticular injection and fascia block for total knee arthroplasty</measure>
    <time_frame>postoperative 24  hours</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Patients were  assigned in two groups to perform  either periarticular injection (group PI) and fascia block ( group FB). They were accessed by visual analog scale. The aim was to compare the efficacy and side effects of periarticular injection and fascia block.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">66</enrollment>
  <condition>Total Knee Arthroplasty</condition>
  <arm_group>
    <arm_group_label>group PI</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>group PI were performed periarticular drug injection during surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>group FI</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>group FI were performed fascia iliaca block  before surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>periarticular injection</intervention_name>
    <description>patients were performed bupivacaine solution to the periarticular soft tissues during surgery by the surgeon.</description>
    <arm_group_label>group PI</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>fascia iliaca block</intervention_name>
    <description>patients were performed fascia iliaca block with bupivacaine solution before surgery.</description>
    <arm_group_label>group FI</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients undergoing knee arthroplasty

          -  &gt; 18 years of age

        Exclusion Criteria:

          -  obesity

          -  heart failure

          -  kidney failure

          -  liver failure
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anis Aribogan, Prof.,MD</last_name>
    <role>Study Director</role>
    <affiliation>Baskent University School of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Baskent University School of Medicine Adana Teaching and reserach Hospital</name>
      <address>
        <city>Adana</city>
        <zip>01250</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 27, 2014</lastchanged_date>
  <firstreceived_date>January 23, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Baskent University</investigator_affiliation>
    <investigator_full_name>CAGLA BALI,MD</investigator_full_name>
    <investigator_title>MD,Anesthesiology and Reanimation</investigator_title>
  </responsible_party>
  <keyword>periarticular drug injection</keyword>
  <keyword>fascia iliaca block</keyword>
  <keyword>knee arthroplasty</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
